Page 18 - ARNM-2-4
P. 18

Advances in Radiotherapy
            & Nuclear Medicine                                                        Radionuclide-carrying liposomes



               In vitro stability, imaging, and biodistribution in rats. J Nucl      doi: 10.1136/jitc-2020-001341
               Med. 2003;44(12):1992-1999.
                                                               33.  Andón FT, Digifico E, Maeda A, et al. Targeting
            22.  Goins B, Klipper R, Rudolph AS, Cliff RO, Blumhardt R,   tumor  associated macrophages:  The  new challenge  for
               Phillips WT. Biodistribution and imaging studies of   nanomedicine. Semin Immunol. 2017;34:103-113.
               technetium-99m-labeled liposomes in rats with focal      doi: 10.1016/j.smim.2017.09.004
               infection. J Nucl Med. 1993;34(12):2160-2168.
                                                               34.  Nosova AS, Koloskova OO, Nikonova AA, et al. Diversity
            23.  Goins B, Klipper R, Rudolph AS, Phillips WT. Use of   of PEGylation methods of liposomes and their influence on
               technetium-99m-liposomes in tumor imaging. J Nucl Med.   RNA delivery. Medchemcomm. 2019;10(3):369-377.
               1994;35(9):1491-1498.
                                                                  doi: 10.1039/c8md00515j
            24.  Boerman OC, Rennen H, Oyen WJ, Corstens FH.
               Radiopharmaceuticals to image infection and inflammation.   35.  Klibanov AL, Maruyama K, Torchilin VP, Huang L.
               Semin Nucl Med. 2001;31(4):286-295.                Amphipathic polyethyleneglycols effectively prolong the
                                                                  circulation time of liposomes. FEBS Lett. 1990;268(1):
               doi: 10.1053/snuc.2001.26189                       235-237.
            25.  Phillips WT, Klipper R, Goins B. Use of (99m)Tc-labeled      doi: 10.1016/0014-5793(90)81016-h
               liposomes encapsulating blue dye for identification of the
               sentinel lymph node. J Nucl Med. 2001;42(3):446-451.  36.  Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics
                                                                  of pegylated liposomal doxorubicin: Review of animal
            26.  Zavaleta CL, Goins BA, Bao A, McManus LM, McMahan CA,   and human studies.  Clin Pharmacokinet. 2003;42(5):
               Phillips WT. Imaging of 186Re-liposome therapy in ovarian   419-436.
               cancer xenograft model of peritoneal carcinomatosis. J Drug
               Target. 2008;16(7):626-637.                        doi: 10.2165/00003088-200342050-00002
               doi: 10.1080/10611860802230372                  37.  Rommasi F, Esfandiari N. Liposomal nanomedicine:
                                                                  Applications for drug delivery in cancer therapy. Nanoscale
            27.  Lobatto ME, Binderup T, Robson PM,  et al. Multimodal   Res Lett. 2021;16(1):95.
               positron emission tomography imaging to quantify uptake
               of  Zr-labeled liposomes in the atherosclerotic vessel wall.      doi: 10.1186/s11671-021-03553-8
                 89
               Bioconjug Chem. 2019;31(2):360-368.             38.  Ta T, Porter TM. Thermosensitive liposomes for localized
               doi: 10.1021/acs.bioconjchem.9b00256               delivery and triggered release of chemotherapy. J  Control
                                                                  Release. 2013;169(1-2):112-125.
            28.  Jeong HY, Kang SJ, Kim MW,  et al. Development
               of PET radioisotope copper-64-labeled theranostic      doi: 10.1016/j.jconrel.2013.03.036
               immunoliposomes for EGFR overexpressing cancer-  39.  Stolarz AJ, Chhetri BP, Borrelli MJ,  et al. Liposome
               targeted therapy and imaging. Int J Mol Sci. 2024;25(3):1813.  formulation for tumor-targeted drug delivery using
               doi: 10.3390/ijms25031813                          radiation therapy. Int J Mol Sci. 2022;23(19):11662.
            29.  Kelly C, Jefferies C, Cryan SA. Targeted liposomal drug      doi: 10.3390/ijms231911662
               delivery to monocytes and macrophages.  J  Drug Deliv.   40.  Prabhakar A, Banerjee R. Nanobubble liposome complexes
               2011;2011:727241.                                  for diagnostic imaging and ultrasound-triggered drug
               doi: 10.1155/2011/727241                           delivery in cancers: A  theranostic approach.  ACS Omega.
                                                                  2019;4(13):15567-15580.
            30.  Umeda IO, Koike Y, Ogata M,  et al. New liposome-
               radionuclide-chelate combination for tumor targeting      doi: 10.1021/acsomega.9b01924
               and  rapid  healthy  tissue  clearance.  J  Control Release.   41.  Amirrashedi M, Jensen AI, Tang Q, et al. The influence of size
               2023;361:847-855.                                  on the intracranial distribution of biomedical nanoparticles
               doi: 10.1016/j.jconrel.2023.07.060                 administered by convection-enhanced delivery in minipigs.
                                                                  ACS Nano. 2024;18(27):17869-17881.
            31.  La-Beck NM, Liu X, Wood LM. Harnessing liposome
               interactions with the immune system for the next      doi: 10.1021/acsnano.4c04159
               breakthrough in cancer drug delivery.  Front Pharmacol.   42.  Phillips WT, Goins B, Bao A, et al. Rhenium-186 liposomes
               2019;10:220.                                       as convection-enhanced nanoparticle brachytherapy
                                                                  for treatment of glioblastoma.  Neuro  Oncol. 2012;14(4):
               doi: 10.3389/fphar.2019.00220
                                                                  416-425.
            32.  Li C, Xu X, Wei  S, Jiang P, Xue L, Wang  J. Tumor-
               associated macrophages: Potential therapeutic strategies      doi: 10.1093/neuonc/nos060
               and future prospects  in cancer.  J  Immunother Cancer.   43.  Phillips WT, Bao A, Brenner AJ, Goins BA. Image-guided
               2021;9(1):e001341.                                 interventional therapy for cancer with radiotherapeutic


            Volume 2 Issue 4 (2024)                         10                             doi: 10.36922/arnm.4373
   13   14   15   16   17   18   19   20   21   22   23